Summary
SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economic development, education and learning, energy and green tech, security and defense, sensing, space and radar, security and defense, robotics among others. SRI’s biomedical sector offers basic research on disease mechanisms, biologic drug discovery and development, nonclinical contract services, laboratory experiments, computer simulations, testing, behavioral pharmacology and other programs. It serves government, corporations, commercial businesses, startup companies, industry consortiums, private foundations and venture firms in the US. SRI is headquartered in Menlo Park, California, the US.
SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SRI International, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SRI International, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SRI International, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SRI International, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SRI International, Medical Devices Deals, 2011 to YTD 2017 9
SRI International, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SRI International, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 11
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 12
SRI International Enters into Contract for PREVENT Cancer Program 13
SRI International Enters into Biological Testing Facility Contract with NICHD 14
SRI International Enters into Agreement with National Institute of Allergy and Infectious Diseases 15
Lux Research Enters into Agreement with SRI International 16
Sareum And SRI International Enter Into Co-Development Agreement For Autoimmune And Inflammatory Diseases 17
Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD 18
Licensing Agreements 19
SRI International Enters into Licensing Agreement with Nobelpharma 19
Asset Transactions 20
Helix Twelve Pharma Acquires Rights to HLX-801 from SRI International 20
SRI International - Key Competitors 21
SRI International - Key Employees 22
SRI International - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Strategy And Business Planning 26
Apr 21, 2016: SRI International Spins Off Superflex to Help People Achieve Their Physical Potential 26
Corporate Communications 27
May 19, 2016: SRI International Appoints Two New Leaders to its Executive Team 27
Mar 22, 2016: SRI International Adds New Members to Board of Directors 29
Government and Public Interest 30
Dec 06, 2016: SRI Awarded $150 Million NIAID-DAIDS Contract to Provide Development and Manufacturing Support for Promising HIV-Prevention Products 30
Oct 20, 2016: SRI International’s Parijat Bhatnagar Wins Prestigious NIH New Innovator Award 31
Mar 10, 2016: SRI International Receives $19.8 Million National Cancer Institute Contract for PREVENT Cancer Program 32
Product News 33
04/27/2017: SRI International Awarded $4.7 Million in Agreements to Manufacture and Test Vaccine Against Venezuelan Equine Encephalitis 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
SRI International, Pharmaceuticals & Healthcare, Key Facts 2
SRI International, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SRI International, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SRI International, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SRI International, Deals By Therapy Area, 2011 to YTD 2017 8
SRI International, Medical Devices Deals, 2011 to YTD 2017 9
SRI International, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 11
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 12
SRI International Enters into Contract for PREVENT Cancer Program 13
SRI International Enters into Biological Testing Facility Contract with NICHD 14
SRI International Enters into Agreement with National Institute of Allergy and Infectious Diseases 15
Lux Research Enters into Agreement with SRI International 16
Sareum And SRI International Enter Into Co-Development Agreement For Autoimmune And Inflammatory Diseases 17
Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD 18
SRI International Enters into Licensing Agreement with Nobelpharma 19
Helix Twelve Pharma Acquires Rights to HLX-801 from SRI International 20
SRI International, Key Competitors 21
SRI International, Key Employees 22
SRI International, Other Locations 24
SRI International, Subsidiaries 25
List of Figures
SRI International, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
SRI International, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
SRI International, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
SRI International, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
SRI International, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SRI International, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
SRI International, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SRI International, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SRI International, Medical Devices Deals, 2011 to YTD 2017 9
